LV15558A - Selenophenochromene phosphonic acids, preparation and use as antiproliferative agents - Google Patents

Selenophenochromene phosphonic acids, preparation and use as antiproliferative agents

Info

Publication number
LV15558A
LV15558A LVP-19-46A LV190046A LV15558A LV 15558 A LV15558 A LV 15558A LV 190046 A LV190046 A LV 190046A LV 15558 A LV15558 A LV 15558A
Authority
LV
Latvia
Prior art keywords
selenophenochromene
phosphonic acids
antiproliferative agents
preparation
disorders
Prior art date
Application number
LVP-19-46A
Other languages
Latvian (lv)
Inventor
Pavels Arsenjans
Ilona Domračeva
Edgars PAEGLE
Original Assignee
Latvijas Organiskās Sintēzes Institūts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Latvijas Organiskās Sintēzes Institūts filed Critical Latvijas Organiskās Sintēzes Institūts
Priority to LVP-19-46A priority Critical patent/LV15558A/en
Priority to PCT/IB2020/052685 priority patent/WO2021038306A1/en
Publication of LV15558A publication Critical patent/LV15558A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6552—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
    • C07F9/65522—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to a novel selenophenochromene phosphonic acids as antiproliferative agents, as well as methods of their manufacturing and use in different pharmaceutical compositions for the treatment or prevention of various diseases and disorders by administration of such substances.
LVP-19-46A 2019-08-28 2019-08-28 Selenophenochromene phosphonic acids, preparation and use as antiproliferative agents LV15558A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
LVP-19-46A LV15558A (en) 2019-08-28 2019-08-28 Selenophenochromene phosphonic acids, preparation and use as antiproliferative agents
PCT/IB2020/052685 WO2021038306A1 (en) 2019-08-28 2020-03-23 Selenophenochromene phosphonic acids, preparation and use as antiproliferative agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LVP-19-46A LV15558A (en) 2019-08-28 2019-08-28 Selenophenochromene phosphonic acids, preparation and use as antiproliferative agents

Publications (1)

Publication Number Publication Date
LV15558A true LV15558A (en) 2021-03-20

Family

ID=68382473

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-19-46A LV15558A (en) 2019-08-28 2019-08-28 Selenophenochromene phosphonic acids, preparation and use as antiproliferative agents

Country Status (2)

Country Link
LV (1) LV15558A (en)
WO (1) WO2021038306A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3029911C (en) 2016-07-21 2019-12-10 Latvian Institute Of Organic Synthesis Antimetastatic 2h-selenopheno[3,2-h]chromenes, synthesis thereof, and methods of using same agents

Also Published As

Publication number Publication date
WO2021038306A1 (en) 2021-03-04

Similar Documents

Publication Publication Date Title
MX2021004431A (en) Novel processes.
WO2017053868A8 (en) C4-modified oleanolic acid derivatives for inhibition of il-17 and other uses
WO2018060732A3 (en) Compositions and methods for treating seizure disorders
WO2019032662A8 (en) Clec9a binding agents and use thereof
WO2017194782A3 (en) Therapeutic targeting of non-cellular structures
MX2016010213A (en) Novel pharmaceutical formulations.
MX2021015936A (en) Methods of making bempedoic acid and compositions of the same.
PH12020550341A1 (en) Niraparib formulations
WO2017022962A8 (en) Composition for preventing or treating immune disease, comprising ripk inhibitor as active ingredient
EA201992607A1 (en) SOLID FORMS OF UBERODESOXYCHOLATE BERBERIN, THEIR COMPOSITIONS AND METHODS
WO2018111315A8 (en) PYRIMIDINE TRICYCLIC ENONE DERIVATIVES FOR INHIBITION OF RORγ AND OTHER USES
PH12021550872A1 (en) Therapeutic compounds
SG10201907289VA (en) Monomethylfumarate prodrug compositions
MX2022000712A (en) Nlrp3 modulators.
MX2021004860A (en) Novel pyridazines.
PH12019502510A1 (en) Pharmaceutical composition and pharmaceutical dosage form comprising (e)-4-(2-(aminomethyl)-3-fluoroallyloxy)-n-tert-butylbenzamide, process for their preparation, methods for treating and uses thereof
WO2015048188A3 (en) Modified fibroblast growth factors for the treatment of ocular disorders
MX2023003348A (en) Compounds and compositions as modulators of tlr signaling.
MX2020001256A (en) Compounds for the prevention and treatment of medical disorders and uses thereof.
CR20210499A (en) Compounds and compositions as modulators of tlr signaling
MX2022004382A (en) Methods of promoting scfa production by gut microbiota.
JP2019529569A5 (en)
LV15558A (en) Selenophenochromene phosphonic acids, preparation and use as antiproliferative agents
MX2019009909A (en) Pharmaceutical compositions for combination therapy.
WO2017106798A3 (en) Compositions and methods for treating gluten intolerance and disorders arising therefrom